Pharmaceutical

Vermeulens has released its market outlook report for the third quarter of 2022. Key points include:

Thor Equities opened a 350,000-sf research facility in Jersey City in October of 2022. Designed by SGA, the adaptive reuse project transformed a former toothpaste factory into a vibrant R&D center offering leasable lab and office environments. Featuring a selection of suites with infrastructure, casework, and equipment already installed, the eight-story structure integrates flexible floor plates, multiple utility grids, an onsite life safety generator, and 125 underground parking spaces.

King Street Properties broke ground in October of 2022 on the $915 million Allston LabWorks complex in Boston. Designed by DiMella Shaffer, the vibrant life sciences campus will provide 534,000 sf of leading-edge lab and office space across two research buildings. Standing six and eight stories high, the highly efficient structures will feature generous floor-to-floor heights to accommodate sophisticated instrumentation.

Amgen opened a 245,000-sf R&D center in South San Francisco in October of 2022. Located on the Gateway of Pacific life sciences campus in Oyster Point, the leased facility was designed by Flad Architects and developed by BioMed Realty. Featuring modular wet and molecular labs, the nine-story tower accommodates Amgen's research programs in oncology, inflammation, and cardiometabolic diseases. Flexible floor plates integrate lab and office functions, with open work spaces and movable furnishings promoting collaboration and interaction.

Johnson & Johnson opened its San Francisco Bay Campus in September of 2022 in Brisbane, Calif. Accommodating up to 400 employees, the 200,000-sf facility bridges key scientific and technological capabilities by collocating the biomedical research activities of subsidiary firm Janssen Pharmaceuticals with J&J's innovation and technology divisions. The collaborative R&D hub houses leading-edge laboratories, flexible office environments, and space for joint development with industry partners.

CSL completed construction in September of 2022 on its $150 million R&D campus in Marburg, Germany. Located in the Görzhausen Industrial Park, the 430,000-sf facility offers sophisticated environments for the creation of next-generation mRNA vaccines, recombinant technologies, and cell and gene therapies. Accommodating up to 500 employees, the multidisciplinary complex represents CSL’s largest global research hub with 75,000 sf of lab space and 75,000 sf of office space.

Sartorius is constructing the $60 million Center of Excellence for BioAnalytics in Ann Arbor, Mich. Designed by Hobbs+Black Architects, the 130,000-sf building will include a process development lab to accelerate the creation of advanced medical therapies. Providing next-generation facilities for biopharmaceutical research, development, production, and testing, the project will enable the company to consolidate business operations currently dispersed throughout Washtenaw County and beyond.

Thermo Fisher Scientific opened a 300,000-sf viral vector center in August of 2022 in Plainville, Mass. Accelerating the creation of advanced cell and gene therapies, the cGMP-compliant facility offers flexible laboratories and production suites for the development, testing, and manufacture of viral vectors. Featuring Thermo Fisher’s advanced bioprocessing technologies and analytical instrumentation, the sustainably designed structure also includes sophisticated office environments and adjacent warehouse spaces.

Pfizer is expanding its Chesterfield campus with the construction of a $60 million addition to support vaccine research and development. Providing leading-edge labs, offices, and support spaces, the three-story, 37,000-sf project will adjoin an existing 261,000-sf facility that opened in 2019. A two-story bridge with a covered plaza will link the completed structure to the rest of the 31-acre site. 

Breakthrough Properties began construction in August of 2022 on the One Canal life sciences center in Cambridge, Mass. Designed to accommodate either a single tenant or multiple companies, the project involves the renovation of an existing structure to provide 105,000 sf of best-in-class biomedical research space. Occupants will enjoy private outdoor meeting venues, integrated retail amenities, and a fitness center.

Longfellow Real Estate Partners broke ground in August of 2022 on a 323,000-sf life sciences center in San Diego. Designed by HOK, the six-story Bioterra development will provide leading-edge laboratories, offices, and collaboration spaces for biomedical and pharmaceutical tenants. Occupants will enjoy a lush rooftop patio offering inspiring views, with specially curated food and beverage options on the lower levels open to the public.

BioMed Realty is constructing a 495,000-sf life sciences facility at Assembly Innovation Park in Somerville, Mass. Designed by Perkins&Will, the 12-story lab and office tower will provide leasable research environments for biomedical, pharmaceutical, and technology companies. With a floor-to-floor height of 15 feet, the building will offer floor plates of approximately 45,000 sf serviced by robust mechanical and electrical infrastructure.

Lincoln Property Company is planning to break ground in early 2023 on a 650,000-sf life sciences center in Boston. Designed by Arrowstreet, Moody Nolan, and Studio Eneé, Seaport Circle will provide Class A lab and office environments for biomedical and pharmaceutical tenants. Two adjoining towers topped by green roof decks will offer flexible, column-free floor plates ranging from 25,000 sf to 70,000 sf.

The University of Cambridge opened the Heart and Lung Research Institute in the United Kingdom in July of 2022. Created in partnership with the Royal Papworth Hospital NHS Foundation Trust, the £60 million facility features state-of-the-art labs for cellular, molecular, and translational research. Accommodating 380 academic and industry scientists, the 86,000-sf project houses a high-throughput characterization suite, a genetics and functional genomic center, the relocated Cardiovascular Epidemiology Unit, and the 10-bed Clinical Research Facility.

Albany College of Pharmacy and Health Sciences has acquired an existing life sciences facility to house the Center for Biopharmaceutical Education and Training. Sited adjacent to the school's campus in Albany, New York, the 154,000-sf structure is uniquely designed for biomedical research with over 60,000 sf of BSL-2 and BSL-3 laboratory space. The five-story building will be renovated to create dedicated gene therapy labs, mammalian cell labs, teaching wet labs, biopharmaceutical pilot plants, and fermentation and downstream processing facilities.